ESMO 2025 – Global Perspectives in Current and Future Management of Lung Cancer
Explore expert insights on lung health, featuring the latest research, therapeutic breakthroughs, and practical guidance for clinical decision-making.
Berlin, Germany, October 20, 2025
FACULTY CHAIR
Corey J. Langer, MD, FACP
University of Pennsylvania, Philadelphia, USA
FACULTY MEMBERS
Benjamin Besse, MD, PhD
Gustave Roussy and Paris-Saclay University
Solange Peters, MD, PhD
University Hospital of Lausanne
Luis Paz-Ares, MD, PhD
Hospital Universitario 12 de Octubre
Roy Herbst, MD, PhD
Yale Cancer Center
Julie Brahmer, MD
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Marina Chiara Garassino, MD
University of Chicago
Heather Wakelee, MD
Stanford Cancer Institute
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- Optimize IO ± Chemo Strategies in Metastatic NSCLC
- Expand Approaches in Stage IV EGFR-Mutated NSCLC
- Targeted Therapy Beyond EGFR in Stage IV NCSCL
- Small Cell Lung Cancer and Mesothelioma
- Stage I-III NSCLC: Immunotherapy and Targeted Therapy
